MATRIX TABLET DOSAGES FORM AS MOST FASCINATING MEMBER OF CONVENTIONAL DRUG DELIVERY SY TEM-A REVIEW
Keywords:
Polymer, Matrix system, Novel Drug delivery system, patents, technique Controlled ReleaseAbstract
In the present investigation Matrix tablets serves as a vital instrument for oral controlled dosage forms. Disputes like patient consistence, drug focusing on, neighborhood reactions, successive organization and vacillations in blood fixation levels, connected with their partners, the routine measurements structures were amended. Several of the pharmaceutical dosage form are formulated as controlled release dosage form to delay the release of a therapeutic agent such that its appearance in the systemic course is delayed and its plasma profile is managed in term. Tablets offer the least cost way to deal with controlled sustained release dosage forms. Matrix tablet as controlled discharge has given another leap forward for novel medication conveyance framework in the field of pharmaceutical innovation. This review concentrates on the different sorts of lattice frameworks in light of polymer utilized and porosity of network framework i.e. hydrophilic, hydrophobic, fat wax, permeable, non-permeable, pH sensitive.
Downloads
References
Brahmankar DM, Jaiswal S.B. Biopharmaceutics and Pharmacokinetics, A Treatise. 1st edn, Vallabh Prakashan. 335?356,(2005).
Lippincot Wiliams and Wilkins Remington. The science and practice of pharmacy, 21st edn, vol?1, 229-938,(2005).
Mc Conville JT. Recent trends in oral drug delivery. Dru Del Re Autumn / winter. 2005; 24-26.
Robinson Joseph R.Controlled-Release Drug-Delivery Systems, Chapter-27, Remington: The Science and Practice of Pharmacy, Lippincott Williams and Wilkins, 20th Edition,Vol. 1 903-905,(2002).
Chein Y.W. Novel drug delivery Systems. 2nd edn, Marcel Dekker, 139?196,(2002).
Kumar S.Matrix Tablets as Controlled drug delivery systems. Indo American Journal of Pharmaceutical Research. 2011;1(4): 343-350.
Lachman L, Lieberman HA, Kanig Joseph L. The theory and practice of Industrial pharmacy. Varghese publishing house, 3rd ed, 1990; 346.
Harland RS. Drug-polymer matrix swelling and dissolution. Pharm Res 1988; 5: 488-94.
Kumar Kiran S. Matrix Tablets as Controlled drug delivery systems. Indo American Journal of Pharmaceutical Research. 2011; 1(4): 343-350.
Sayed I.Preparation and comparative evaluation of sustained release metoclopramide hydrochloride matrix tablets. Saudi Pharmaceutical Journal. 2009;17:283-288.
Chandran S.Design and evaluation of Ethyl Cellulose Based Matrix Tablets of Ibuprofen with pH Modulated Release Kinetics. Indian Journal of Pharmaceutical Sciences. 2008; 70(5): 596–602.
Patra Chinam N. Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride. Acta Pharm. 2007; 57: 479–489.
Siepmann J.HPMC matrices for controlled drug delivery: new model combining diffusion, swelling and dissolution mechanisms and predicting the release kinetics. Pharm Research. 2000; 16: 1748-1756.
Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of Pharmaceutical Sciences. 1963; 52: 1145-1149.
Suvakanta D. Kinetic modelling on drug release from controlled drug delivery system. Acta Poloniae pharmaceutical and drug research.2010;67(3):217-223.
Shruti C. Release modulating hydrophilic matrix systems of losartan potassium: Optimization of formulation using statistical experimental design. European Journal of Pharmaceutics and Biopharmaceutics.2007; 66:73–82.
Vyas SP, Khar RK. Controlled Drug Delivery: Concepts and Advances. Ist ed. vallabh prakashan. 2002:156-189.
Borguist P.A model for the drug release from a polymeric matrix tablets-effect of swelling and dissolution. Journal of Controlled Release. 2006; 113: 216-225.
Vyas SP, Khar RK. Controlled Drug Delivery Concepts and Advances. 1st ed., New Delhi: Vallabh Prakashan. 2010:1-12.
Borguist P.A model for the drug release from a polymeric matrix tablets-effect of swelling and dissolution. J Controlled Release. 2006; 113: 216-225.
Nishihata T.Overall mechanisms behind matrix sustained release (SR) tablets prepared with hydroxypropyl cellulose. Journal of Controlled Release. 1995; 35: 59-66.
Siepmann J.HPMC matrices for controlled drug delivery: new model combining diffusion, swelling and dissolution mechanisms and predicting the release kinetics. Pharm Research. 2000; 16: 1748-1756.
RN Prykhodko.Trimetazidine dihydrochloride- containing medication in the form of an extended-release matrix tablet (variants) and methods for preparing same (variants). WO2011008183, assigned to Tatyana Leonidovna; 2011.
R Kshirsagar. Extended release compositions containing tolterodine and process for preparing the same. WO/2011/061616, assigned to M/s Lex Orbis (Intellectual Property Practice); 2011.
S Federico.Process for the preparation of controlled release tablet. WO/2011/157730, assigned to C. Colombo ang. via Appiani (Corte del Cotone); 2011.
F Thomas.Extended release tablet formulation containing pramipexole or pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof. Japanese Paten. JP2011084577, assigned to Aisin Seiki Co Ltd; 2011
GE Amidon.Sustained-release tablet comprising reboxetine. Japanese Patent JP2009185051, assigned to Pharmacia Corporation; 2009.
GE Amidon. Sustained release tablet comprising pramipexole. EP2172199, assigned to Pharmacia Corporation; 2010
E Mathiowitz. Controlled regional oral delivery. EP178902, assigned to Spherics, Inc.; 2007
CG Jang. Dry direct compression compositions for controlled release dosage forms. WO/1984/004674, assigned to Jang Choong Gook; 1984.
Allen, Loyd.Rapidly dissolving oral dosage form. WO/1995/020377, assigned to Janssen Pharmaceutica, Inc; 1995.
Brandley MA. Pharmaceutical compositions and methods. WO/2006/089215, assigned to Glaxo Group Ltd; 2006
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
